Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company manufactures pharmaceutical formulations for the overseas.
Medicamen Biotech Limited, is an unlisted public company incorporated on 22 December, 1993. It is classified as a public limited company and is located in , Delhi. It's authorized share capital is INR 15.00 cr and the total paid-up capital is INR 13.56 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Vimal Kumar Shrawat | 08274190 | 7 years |
| Director | Sumita Dwivedi | 08218640 | 7 years |
| Director | Sangeeta Bishnoi | 08288998 | 7 years |
| Director | Ravi Kumar Bansal | 08462513 | 7 years |
| Director | Sanjay Bansal
Shareholder
|
00121667 | 10 years |
| Director | Ashwani Kumar Sharma | 00325634 | 10 years |
| Director | Suresh Kumar Singh | 00318015 | 10 years |
| Director | Harish Pande | 01575625 | 10 years |
| Director | Rahul Bishnoi | 00317960 | 10 years |
| Director | Arun Kumar | 07031730 | 10 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
IndusInd Bank Limited
No. of Loans: 3
Total Amount : 35.4 cr
CitiBank N.A.
No. of Loans: 1
Total Amount : 20.0 cr
AU SMALL FINANCE BANK LIMITED
No. of Loans: 1
Total Amount : 9.0 cr
MERCEDES-BENZ FINANCIAL SERVICES INDIA PRIVATE LIMITED
No. of Loans: 1
Total Amount : 1.2 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 0.3 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| J B SPINTEX PRIVATE LIMITED |
Active
|
5.8 L | 1 | Delhi |
| VERSATILE LAND BASE PRIVATE LIMITED |
Active
|
8.0 L | 1 | Delhi |
| VERSATILE TECHCON PRIVATE LIMITED |
Active
|
13.2 L | 1 | Delhi |
| GENIUS CONSTRUCTIONS PRIVATE LIMITED |
Active
|
5.5 L | 1 | Delhi |
| SM POLYTEX PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Delhi |
| SHIVALIK RASAYAN LIMITED |
Active
|
7.9 Cr | 8 | Uttarakhand |
| MEDICAMEN LIFE SCIENCES PRIVATE LIMITED |
Active
|
4.0 Cr | 2 | Delhi |
| GROWEL REMEDIES LIMITED |
Active
|
24.6 L | 2 | |
| C.J.GELATINE PRODUCTS LIMITED |
Active
|
4.8 Cr | 1 | Maharashtra |
| SUPER SYSTEMS INDIA PRIVATE LIMITED |
Active
|
20.0 L | 1 | Delhi |
| CHEM PHARMA HEALTHCARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
Read more
The incorporation date of MEDICAMEN BIOTECH LIMITED is 22 December, 1993
The authorized share capital of MEDICAMEN BIOTECH LIMITED is INR ₹ 15.0 Cr.
The paid-up capital of MEDICAMEN BIOTECH LIMITED is INR ₹ 13.6 Cr.
The registered address of MEDICAMEN BIOTECH LIMITED is 1506, Chiranjiv Tower, 43, Nehru Place, South Delhi, New Delhi, Delhi, India, 110019 - 110019
The CIN number of MEDICAMEN BIOTECH LIMITED is L74899DL1993PLC056594.